Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RG-101 is a hepatocyte-targeted N-acetylgalactosamine conjugated oligonucleotide that functions as an antagonist for miR-122, an essential host factor in the replication of the hepatitis C virus (HCV).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | Inquiry | $ 1,520.00 |
Description | RG-101 is a hepatocyte-targeted N-acetylgalactosamine conjugated oligonucleotide that functions as an antagonist for miR-122, an essential host factor in the replication of the hepatitis C virus (HCV). |
In vitro | RG-101 is a phosphorothioate oligonucleotide composite that functions as an inhibitor of miR-122. It features a multivalent N-acetylgalactosamine carbohydrate structure, purposefully engineered to improve its absorption by hepatocytes via interaction with the asialoglycoprotein receptor on these cells[1]. |
Molecular Weight | N/A |
CAS No. | 1929655-04-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
RG-101 1929655-04-8 RG 101 RG101 inhibitor inhibit